Auren Rx Review: The Price Selector Defaults to the Dearer Drug

Auren Rx does something we would like every telehealth seller to copy: on every single product it publishes two prices side by side — a discounted subscription rung and an explicit "monthly, no commitment" rung — in plain HTML, before you have answered anything. That structure makes the trade-off legible in a way almost nothing else in this market manages. It is also, on the weight-loss page, wired in a way that will hand a careless reader the wrong number three separate ways.

Both of those things are true, and the second is not a reason to dismiss the first.

Two rungs on everything

Standard compounded semaglutide is $199 a month with no commitment, or $169 if you subscribe. Standard tirzepatide is $299 with no commitment, or $259 subscribed. There is a separately branded microdose program with its own page and its own ladder: semaglutide at $149 no-commitment or $129 subscribed, tirzepatide at $250 or $229.

We file the no-commitment figures. That is the price of buying one month and stopping, and it is the only figure that means the same thing to every reader regardless of how long they end up staying.

The same two-rung structure runs across the rest of the catalog, and the discount is a flat per-product amount rather than a percentage — NAD+ saves $30 a month subscribed, sermorelin $40, glutathione $20, GHK-Cu and tretinoin and oral minoxidil $10 each. We checked that arithmetic against the rendered price on six product pages and it held every time.

Terms are month-to-month and cancellable at any time. Billing runs approximately every 28 to 30 days, which is slightly shorter than a calendar month — but it is disclosed on the site, which is the difference between a quirk and a trap.

The three ways to read this site wrong

This is the part worth your attention, because all three are live right now and all three push the same direction.

The selector opens on tirzepatide. The weight-loss page ships with its molecule selector pre-set to the second option. If you land on that page, look at the price and write it down, you have written down tirzepatide's number — and if you came looking for semaglutide, you have just filed $299 for a $199 product. Nothing on the page is hidden; the default is simply not the one most visitors are looking for.

Its own structured data emits the cheaper rung. The machine-readable product markup Auren Rx publishes for search engines carries the subscribe price, not the no-commitment price. Anything reading that markup — a comparison engine, a shopping feed, an AI assistant summarizing the page — records $169 and $259. Those are real, purchasable prices, but they are the committed ones, and they are not what a reader who buys one month pays.

The navigation's "from" price is a different program. The GLP-1 menu says semaglutide and tirzepatide from $129 a month. That $129 is the microdose semaglutide subscribe rung. The cheapest standard GLP-1 rung is $169 subscribed, $199 monthly. Nothing here is fabricated — $129 buys something real — but a "from" price displayed under a heading that names two standard drugs understates the standard program by seventy dollars a month.

None of these is a lie. All three are the mechanics by which an accurate site produces an inaccurate number in someone's notebook. We record them because our entire job on this axis is to be the notebook that got it right.

The gap: it never says where it operates

Auren Rx's terms refer to services being available to people located in "certain states" and to being in "a state where we operate". Nowhere on the site is there a list.

This is the single largest hole in an otherwise unusually good disclosure record, and it is worse than it sounds for a prescription service. Telehealth prescribing rules are state law, not federal, and whether a compounded GLP-1 can be shipped to you at all is a question with a state-by-state answer. Every other operator we screened in this batch publishes something — a list, a count, a coverage claim. Auren Rx publishes a conditional clause. You will find out whether you are eligible by starting an intake, which is precisely the sequencing this publication objects to elsewhere.

Who prescribes, and who compounds

The medical group is Beluga Health, P.A., described alongside affiliated professional entities. It is a real and established telehealth professional association, but no individual prescriber is named and no NPI is published, so nothing here can be checked against the national provider registry.²

The pharmacy is never named individually either — the site refers to Auren RX or partner pharmacies within an "Auren RX Pharmacy Network". There is one genuinely useful wrinkle: you may elect to use a local pharmacy of your own choosing, in which case the membership fee covers the clinical service and excludes medication cost. That is an option most of this cohort does not offer, and it means the unnamed network is not necessarily the only path.

The legal entity is Hades Capital LLC, doing business as Auren RX, with no address published.

The membership fee, stated precisely

There is a membership fee, it is charged the day membership commences, and it is non-refundable once paid.

The sequencing matters and is in the company's favor: membership begins when a provider has communicated a care plan and you elect to proceed. So the fee follows clinical review rather than preceding it — you are not charged for the privilege of being told no. We looked for a separate always-charged consult fee and did not find one. Fees paid before a cancellation are not refunded, and membership can be paused on demand with no further charges until you order a refill.

Two things we noticed that are not really about price

Two products — valacyclovir and estradiol — exist on the site but are absent from its sitemap. That is a housekeeping observation rather than a red flag, but it is a reminder that reading a sitemap is not the same as reading a catalog, and a review built from the sitemap alone would have missed a tenth of what this company sells.

And every product page carries a star rating between 4.6 and 4.9, with no review count and no source. We are not repeating those figures. A rating with no denominator is a design element, not evidence.

The regulatory screen

We queried the FDA's live warning-letter index for the brand, its legal entity, its medical group and its platform provider. Nothing matched in the company column.³ The pass carried a positive control — a company known to have a real 2026 letter, which returned correctly — because a screen that has quietly broken returns the same empty page as a clean record.

The reason a gut publication is reading pricing tables

Because the alternative most of our readers are actually choosing between is not two telehealth companies. It is a prescription and a plate. The molecules on offer here are the ones that produced roughly 15% mean body-weight loss in their pivotal trials⁴ — a result nothing in the supplement aisle approaches — and they are also the ones whose commonest side effects are gastrointestinal and whose commonest reason for discontinuation is the same.⁵

That is why a no-commitment rung is worth more than a discount. If you do not yet know how your digestion handles a GLP-1, paying $199 to find out and being free to stop is a better structure than paying $169 to be locked in, and what the drugs do to gut motility and symptoms is the thing to read before either.

Where it lands

Auren Rx has the cleanest two-rung price architecture of the seven operators we screened, and the worst state disclosure. If you know your state is served — which you will learn by asking, since the site will not tell you — the pricing is legible, the no-commitment option is explicit, and the arithmetic checks out.

We earn nothing from Auren Rx and there is no tracking link in this article. Its nearest comparisons in this batch are The Edit at $209, which publishes its states and its pharmacy but has no no-commitment/subscribe split, and Trellis Vitality at $150, which publishes a proper term table for GLP-1 and almost nothing for anything else. The whole set sits alongside our prescription GLP-1 review index. Auren Rx is not a program this site links out to; the ones that are, and that print a semaglutide figure before the intake rather than after it, are ranked in our compounded semaglutide ranking.